Oct 26 (Reuters) - Charles River Laboratories International Inc
* Charles River announces expansion of in vitro oncology services
* Charles River Laboratories International Inc says partnership with InSphero AG, supplier of 3D solutions for in vitro drug discovery and development
* Charles River Laboratories International Inc - through partnership, co will license its collection of patient-derived xenograft tumors to InSphero Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)
